Inventor · disambiguated record
Kevin Hodgetts
Also filed as: HODGETTS KEVIN · HODGETTS KEVIN J · HODGETTS KEVIN JULIAN
30 granted patents·28 pending applications·520 citations·filing 2000–2023
96Inventor score
Files withNEUROGEN CORP29BRIGHAM & WOMENS HOSPITAL INC3LUNDBECK & CO AS H3OHIO STATE INNOVATION FOUNDATION3YUMA THERAPEUTICS INC3
Top patents by PatentIndex Score
58 records- 0198US6506762B1Certain alkylene diamine-substituted heterocyclesNEUROGEN CORP·Filed 2000·Granted Jan 14, 2003·227 cites·97 claims
- 0295US6723730B2Capsaicin receptor ligandsNEUROGEN CORP·Filed 2001·Granted Apr 20, 2004·105 cites·185 claims
- 0393US9895358B2Combination therapies for treatment of spinal muscular atrophyUNIV INDIANA RES & TECH CORP·Filed 2017·Granted Feb 20, 2018·11 cites·5 claims
- 0493US7074799B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2003·Granted Jul 11, 2006·48 cites·59 claims
- 0588US7304059B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2006·Granted Dec 4, 2007·10 cites·58 claims
- 0686US9073890B2Therapeutic compounds and related methods of useSUZUKI MASAKI·Filed 2010·Granted Jul 7, 2015·11 cites·7 claims
- 0784US7488740B2Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2004·Granted Feb 10, 2009·17 cites·48 claims
- 0882US7935702B2Substituted biaryl quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2005·Granted May 3, 2011·6 cites·10 claims
- 0981US8580812B2Heteroaryl amide analogues as P2X7 antagonistsIHLE DAVID C·Filed 2008·Granted Nov 12, 2013·9 cites·26 claims
- 1081US7432275B2Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Oct 7, 2008·18 cites·22 claims
- 1180US12286420B2EAAT2 activators and methods of using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2022·Granted Apr 29, 2025·0 cites·19 claims
- 1280US6696445B2Certain alkylene diamine-substituted heterocyclesNEUROGEN CORP·Filed 2002·Granted Feb 24, 2004·11 cites·42 claims
- 1379US2024208936A1Eaat2 activators and methods of using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2023·Application pending·0 cites
- 1477US9630947B2Therapeutic compounds and related methods of useOTSUKA PHARMA CO LTD·Filed 2015·Granted Apr 25, 2017·2 cites·8 claims
- 1577US6420365B1Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptorsNEUROGEN CORP·Filed 2001·Granted Jul 16, 2002·9 cites·40 claims
- 1676US6294530B11-azatricyclic-4-benzylpiperazinesNEUROGEN CORP·Filed 2000·Granted Sep 25, 2001·7 cites·23 claims
- 1775US6509366B2Substituted imidazoles as selective modulators of Bradykinin B2 receptorsNEUROGEN CORP·Filed 2001·Granted Jan 21, 2003·7 cites·46 claims
- 1874US6995161B2Substituted arylpyrazinesNEUROGEN CORP·Filed 2001·Granted Feb 7, 2006·7 cites·91 claims
- 1972US10336768B2Pyrimidine compounds and methods using the sameYUMA THERAPEUTICS INC·Filed 2015·Granted Jul 2, 2019·2 cites·33 claims
- 2072US7179807B25-substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2003·Granted Feb 20, 2007·7 cites·15 claims
- 2169US7074929B2Certain alkylene diamine-substituted heterocyclesPFIZER·Filed 2003·Granted Jul 11, 2006·3 cites·1 claims
- 2268US6943173B25-substituted 2-aryl-4-pyrimidinonesNEUROGEN CORP·Filed 2001·Granted Sep 13, 2005·3 cites·36 claims
- 2367US11702403B2EAAT2 activators and methods of using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Jul 18, 2023·0 cites·19 claims
- 2462US2021363154A1Pyrimidine compounds and methods using the sameYUMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2561US10420753B2Combination therapies for treatment of spinal muscular atrophyUNIV INDIANA RES & TECH CORP·Filed 2018·Granted Sep 24, 2019·0 cites·18 claims
- 2661US9133204B25-membered heterocyclic amides and related compoundsLUNDBECK & CO AS H·Filed 2014·Granted Sep 15, 2015·0 cites·13 claims
- 2760US2024245658A1Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2860US2024189289A1Inhibitors of ephb3 signalingBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 2960US2008015183A1Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 3059US10961254B2Pyrimidine compounds and methods using the sameYUMA THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·0 cites·18 claims
- 3159US2009286767A1Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2009·Application pending·0 cites
- 3259US2024190835A1Isochroman derivatives and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3357US2010292236A15-Membered Heterocyclic Amides And Related CompoundsLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 3455US2004176443A1Capsaicin receptor ligandsNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 3554US2009082362A1Use of capsaicin receptor antagonists to treat symptoms of tear gas exposureBAKTHAVATCHALAM RAJAGOPAL·Filed 2008·Application pending·0 cites
- 3653US7202250B2Substituted arylpyrazinesNEUROGEN CORP·Filed 2005·Granted Apr 10, 2007·0 cites·16 claims
- 3752US7169790B25-substituted 2-aryl-4-pyrimidinonesNEUROGEN CORP·Filed 2005·Granted Jan 30, 2007·0 cites·32 claims
- 3852US2007225287A1Substituted ArylpyrazinesYOON TAEYOUNG·Filed 2007·Application pending·0 cites
- 3951US6403591B11-azatricyclic-4-benzylpiperazinesNEUROGEN CORP·Filed 2001·Granted Jun 11, 2002·0 cites·10 claims
- 4051US2017217923A1Therapeutic compounds and related methods of useOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 4150US2007043056A15-Substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 4250US2014038955A1Heteroaryl amide analogues as p2x7 antagonistsLUNDBECK & CO AS H·Filed 2013·Application pending·0 cites
- 4350US2002193364A11-azatricyclic-4-benzylpiperazinesNEUROGEN CORP·Filed 2002·Application pending·0 cites
- 4447US2006229308A1Substituted pyrirmidin-4-ylamine analogues as vanilloid receptor ligandsNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 4547US2003229076A1Substituted imidazoles as selective modulators of bradykinin B2 receptorsFiled 2002·Application pending·0 cites
- 4646US11377436B2EAAT2 enhancing moleculesBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Granted Jul 5, 2022·0 cites·19 claims
- 4746US2007043049A1Substituted heterocyclic diarylamine analoguesNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 4844US2008085901A1Heteroaryl Substituted Quinolin-4-Ylamine AnaloguesNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 4944US2008132509A1Substituted Biaryl AnaloguesNEUROGEN CORP·Filed 2005·Application pending·0 cites
- 5044US2008175794A1Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine AnaloguesNEUROGEN CORP·Filed 2006·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →